Compare INMD & RPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INMD | RPC |
|---|---|---|
| Founded | 2008 | 1992 |
| Country | Israel | United States |
| Employees | N/A | 267 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 842.0M | 932.7M |
| IPO Year | 2018 | N/A |
| Metric | INMD | RPC |
|---|---|---|
| Price | $14.11 | $8.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $17.33 | $11.00 |
| AVG Volume (30 Days) | ★ 709.8K | 426.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.74 | $16.82 |
| Revenue Next Year | $3.26 | $15.80 |
| P/E Ratio | ★ $10.11 | $53.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.72 | $6.79 |
| 52 Week High | $16.74 | $9.32 |
| Indicator | INMD | RPC |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 55.75 |
| Support Level | $14.00 | $6.94 |
| Resistance Level | $14.70 | $8.88 |
| Average True Range (ATR) | 0.31 | 0.34 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 67.06 | 57.20 |
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Ridgepost Capital Inc, formelrly P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue primarily comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.